Home Arecor

Arecor

In operation
Undisclosed
Biopharmaceutical Provider
Basic
Enterprise Profile

Basic Information

Arecor is at the forefront of developing high-quality biopharmaceuticals by applying its innovative formulation technology platform. Arecor is utilizing this platform to develop a portfolio of proprietary products that aim to improve diabetes treatment through the innovative reformulation of approved proteins and peptides.
Arecor Limited
--
15~50 people
January 01, 2007
info@arecor.com

Enterprise Profile

Industrial Sector
New Drug Development Manufacture of Chemical Pharmaceutical Preparations
Technology
Gene Technology Biotechnology
Concept
# Diabetes Mellitus
Application Scenarios
Biologics Innovative Drugs